Tag: Heart Failure
Risk Tool Can Predict Heart Failure in Patients With Diabetes
AI model integrates readily available clinical, laboratory, and electrocardiographic data
Uptitration of Drugs Varies With Target Dosage in Chronic HF
When target is higher versus lower dosage, uptitration stops further from recommended dosage
Dapagliflozin Lowers Risk for Worsening Heart Failure
Findings seen among patients with heart failure, reduced ejection fraction, irrespective of diabetes
SGLT2 Inhibitors Linked to Lower Risk for Heart Failure
Risk lower for HF, but not major CV events, compared with new users of DPP4 inhibitors
County-Level Poverty Strongly Tied to Heart Failure Mortality
Poverty linked to heart failure and coronary heart disease mortality; link stronger for heart failure
Decline in Heart Failure Mortality Rates Offset by Comorbidities
Treatments focused only on cardiovascular outcomes insufficient for improving heart failure patient survival
Sacubitril-Valsartan Does Not Impact Aortic Stiffness in HFrEF
But it is linked to improvements in cardiac structure, function including decreases in LVESVI, LVEDVI
LV Hypertrophy Predicts Long-Term Risk for CV Events
Left ventricular hypertrophy stronger predictor than CAC for CHD death, other CV death, heart failure
Poor HIV Control Ups Risk for Sudden Cardiac Death in Heart Failure
Lower CD4 count, nonsuppressed viral load linked to higher risk for sudden cardiac death in HIV with heart failure
Type 2 Diabetes Associated With Poorer Outcomes in Heart Failure
Findings include structural abnormalities in the heart, poorer quality of life with T2DM and HF
